Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Infleqtion, Inc.
13D/A
Amendment 1
INFQ · 45676K103
|
3.6% |
5/26/2026
Event 5/21/2026
|
|||
| MCV Management Company, LLC | 3.6% | ||||
| Maverick Capital Management, LLC | 3.6% | ||||
| Maverick Ventures Investment Fund, L.P. | 2.3% | ||||
| Maverick Advisors Fund, L.P. | 1.4% | ||||
| Maverick Capital Ventures, LLC | 3.6% | ||||
| Maverick Silicon Fund, L.P. | 0% | ||||
| Maverick Fund USA, Ltd. | 0% | ||||
| Maverick Designated Investments Fund, L.P. | 0% | ||||
| Maverick Long Fund, Ltd. | 0% | ||||
| Maverick Long Enhanced Fund, Ltd. | 0% | ||||
| Maverick Fund II, Ltd. | 0% | ||||
| Maverick Capital, Ltd. | 3.6% | ||||
| Lee S. Ainslie III | 3.6% | ||||
| David B. Singer | 3.6% | ||||
| Maverick Silicon, L.P. | 0% | ||||
|
Infleqtion, Inc.
13D
INFQ · 45676K103
|
9.2% |
2/18/2026
Event 2/13/2026
|
|||
| MCV Management Company, LLC | 7.4% | ||||
| Maverick Capital Management, LLC | 9.2% | ||||
| Maverick Ventures Investment Fund, L.P. | 4.6% | ||||
| Maverick Advisors Fund, L.P. | 2.9% | ||||
| Maverick Capital Ventures, LLC | 7.4% | ||||
| Maverick Silicon Fund, L.P. | 1.3% | ||||
| Maverick Fund USA, Ltd. | 0.1% | ||||
| Maverick Designated Investments Fund, L.P. | 0.2% | ||||
| Maverick Long Fund, Ltd. | 0% | ||||
| Maverick Long Enhanced Fund, Ltd. | 0.1% | ||||
| Maverick Fund II, Ltd. | 0.1% | ||||
| Maverick Capital, Ltd. | 7.9% | ||||
| Lee S. Ainslie III | 9.2% | ||||
| David B. Singer | 7.4% | ||||
| Maverick Silicon, L.P. | 1.3% | ||||
|
Peabody Energy Corporation
13G/A
Amendment 2
BTU · 704551100
|
3.3% |
2/13/2026
Event 12/31/2025
|
|||
| Maverick Capital, Ltd. | 3.3% | ||||
| Maverick Capital Management, LLC | 3.3% | ||||
| Lee S. Ainslie III | 3.3% | ||||
|
Rocket Pharmaceuticals, Inc.
13G/A
Amendment 2
RCKT · 77313F106
|
2.3% |
2/13/2026
Event 12/31/2025
|
|||
| Maverick Capital, Ltd. | 2.3% | ||||
| Maverick Capital Management, LLC | 2.3% | ||||
| Lee S. Ainslie III | 2.3% | ||||
|
Invivyd, Inc.
13G/A
Amendment 3
IVVD · 00534A102
|
6.7% |
2/13/2026
Event 12/31/2025
|
|||
| Maverick Capital, Ltd. | 6.7% | ||||
| Maverick Capital Management, LLC | 6.7% | ||||
| Lee S. Ainslie III | 6.7% | ||||
|
Fractyl Health, Inc.
13G/A
Amendment 1
GUTS · 35168W103
|
3.1% |
11/14/2025
Event 9/30/2025
|
|||
| Maverick Capital, Ltd. | 3.1% | ||||
| Maverick Capital Management, LLC | 3.1% | ||||
| Lee S. Ainslie III | 3.1% | ||||
|
Curis, Inc.
13G/A
Amendment 4
CRIS · 231269309
|
0.4% |
11/14/2025
Event 9/30/2025
|
|||
| Maverick Capital, Ltd. | 0.4% | ||||
| Maverick Capital Management, LLC | 0.4% | ||||
| Lee S. Ainslie III | 0.4% | ||||
|
Peabody Energy Corporation
13G/A
Amendment 1
BTU · 704551100
|
6.7% |
11/14/2025
Event 9/30/2025
|
|||
| Maverick Capital, Ltd. | 6.7% | ||||
| Maverick Capital Management, LLC | 6.7% | ||||
| Lee S. Ainslie III | 6.7% | ||||
|
Peabody Energy Corporation
13G
BTU · 704551100
|
5.5% |
9/26/2025
Event 9/19/2025
|
|||
| Maverick Capital, Ltd. | 5.5% | ||||
| Maverick Capital Management, LLC | 5.5% | ||||
| Lee S. Ainslie III | 5.5% | ||||
|
Rocket Pharmaceuticals, Inc.
13G/A
Amendment 1
RCKT · 77313F106
|
7.8% |
8/14/2025
Event 6/30/2025
|
|||
| Maverick Capital, Ltd. | 7.8% | ||||
| Maverick Capital Management, LLC | 7.8% | ||||
| Lee S. Ainslie III | 7.8% | ||||
|
Invivyd, Inc.
13G/A
Amendment 2
IVVD · 00534A102
|
8.5% |
8/14/2025
Event 6/30/2025
|
|||
| Maverick Capital, Ltd. | 8.5% | ||||
| Maverick Capital Management, LLC | 8.5% | ||||
| Lee S. Ainslie III | 8.5% | ||||
|
Rocket Pharmaceuticals, Inc.
13G
RCKT · 77313F106
|
5.2% |
4/14/2025
Event 4/7/2025
|
|||
| Maverick Capital, Ltd. | 5.2% | ||||
| Maverick Capital Management, LLC | 5.2% | ||||
| Lee S. Ainslie III | 5.2% | ||||
|
Verona Pharma Plc
13G/A
Amendment 1
VRNA · 925050106
|
3.8% |
2/14/2025
Event 12/31/2024
|
|||
| Maverick Capital, Ltd. | 3.8% | ||||
| Maverick Capital Management, LLC | 3.8% | ||||
| Lee S. Ainslie III | 3.8% | ||||
|
Wave Life Sciences Ltd.
13G/A
Amendment 3
WVE · Y95308105
|
5.4% |
2/14/2025
Event 12/31/2024
|
|||
| Maverick Capital, Ltd. | 5.4% | ||||
| Maverick Capital Management, LLC | 5.4% | ||||
| Lee S. Ainslie III | 5.4% | ||||
|
Curis, Inc.
13G/A
Amendment 3
CRIS · 231269309
|
8.0% |
2/14/2025
Event 12/31/2024
|
|||
| Maverick Capital, Ltd. | 8.0% | ||||
| Maverick Capital Management, LLC | 8.0% | ||||
| Lee S. Ainslie III | 8.0% | ||||